061250 Stock Chart & Stats
₩5600.00
-₩150.00(-2.61%)
―
--
Day’s Range― - ―
52-Week Range₩5,550.00 - ₩12,500.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)18.27K
Market Cap
₩34.03B
Enterprise Value-₩19.17B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)9.8
Beta0.02
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)519.87
Shares Outstanding8,417,584
10 Day Avg. Volume7,164
30 Day Avg. Volume18,266
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Hwail Pharmaceutical Co., Ltd. News
061250 FAQ
What was Hwail Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Hwail Pharmaceutical Co., Ltd. lowest stock price was ₩5550.00 and its highest was ₩12500.00 in the past 12 months.
What is Hwail Pharmaceutical Co., Ltd.’s market cap?
Hwail Pharmaceutical Co., Ltd.’s market cap is ₩34.03B.
When is Hwail Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Hwail Pharmaceutical Co., Ltd.’s upcoming earnings report date is Nov 12, 2026 which is in 12 days.
How were Hwail Pharmaceutical Co., Ltd.’s earnings last quarter?
Hwail Pharmaceutical Co., Ltd. released its earnings results on Aug 13, 2026. The company reported ₩519.874 earnings per share for the quarter.
Is Hwail Pharmaceutical Co., Ltd. overvalued?
According to Wall Street analysts Hwail Pharmaceutical Co., Ltd.’s price is currently Undervalued.
Does Hwail Pharmaceutical Co., Ltd. pay dividends?
Hwail Pharmaceutical Co., Ltd. does not currently pay dividends.
What is Hwail Pharmaceutical Co., Ltd.’s EPS estimate?
Hwail Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hwail Pharmaceutical Co., Ltd. have?
Hwail Pharmaceutical Co., Ltd. has 8,417,584 shares outstanding.
What happened to Hwail Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Hwail Pharmaceutical Co., Ltd. reported an EPS of ₩519.874 in its last earnings report. Following the earnings report the stock price went down -2.278%.
Which hedge fund is a major shareholder of Hwail Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in KR:061250
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Technical Analysis
Yuyu Pharma, Inc.
―
Jin Yang Pharmaceutical Co., Ltd.
―
Samik Pharm Co., Ltd.
―
Aptamer Sciences, Inc.
―
J2KBIO Co., Ltd.
―